CHRISTINE KUSHNER: Open Payments
NPI 1548291990 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,367 in 37 payments from 12 companies in 2025. Trend: 2023 $406 · 2024 $714 · 2025 $1,367
Food & beverage: $1,367
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $310 |
| E.R. Squibb & Sons, L.L.C. | 6 | $214 |
| Otsuka America Pharmaceutical, Inc. | 5 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Axsome Therapeutics, Inc. | 4 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $94 |
| ABBVIE INC. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $29 |
| UCB, Inc. | 1 | $26 |
Products named: COBENFY, LYBALVI, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, Auvelity, SPRAVATO, UZEDY.
Industry payments across PA — which companies pay providers there.
